tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Zegbeh Jallah, 123 are a BUY (95.35%), 6 are a HOLD (4.65%).
Analyst Zegbeh Jallah, currently employed at CAPITAL ONE, carries an average stock price target met ratio of 34.94% that have a potential upside of 32.45% achieved within 188 days. Previously, Zegbeh Jallah worked at ROTH.
Zegbeh Jallah’s has documented 250 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OTLK, OUTLOOK THERAPEUTICS INC at 26-Dec-2023.
Analyst best performing recommendations are on OCGN (OCUGEN).
The best stock recommendation documented was for OCGN (OCUGEN) at 2/3/2021. The price target of $8 was fulfilled within 5 days with a profit of $5.19 (184.7%) receiving and performance score of 369.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
2 years 11 months 19 days ago
(25-Oct-2022)
1/10 (10%)
$13.99 (348.88%)
848
Hold
$0.4
$0.01 (2.56%)
2 years 11 months 19 days ago
(25-Oct-2022)
1/1 (100%)
$0.01 (2.56%)
2
Hold
2 years 11 months 19 days ago
(24-Oct-2022)
0/1 (0%)
$7.55 (308.16%)
Hold
2 years 11 months 20 days ago
(24-Oct-2022)
0/2 (0%)
$2.73 (29.45%)
Hold
$11
3 years 15 days ago
(29-Sep-2022)
0/2 (0%)
$6.72 (157.01%)
What Year was the first public recommendation made by Zegbeh Jallah?
